Myles Wolf
Nephrology · Chicago, ILNPI 1629069927
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,574,409 of the $2,108,424 with a category attached, or 74.7%. Akebia Therapeutics Inc accounts for 62.5% of it on its own, with 16 other manufacturers making up the rest. Among nephrology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 314 payments — averaging $6714.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Akebia Therapeutics Inc$1.3M
- Pharmacosmos Therapeutics Inc.$585K
- AstraZeneca$54K
- CSL Behring$53K
- Astrazeneca AB$51K
- Bayer$17K
- plus $31K from 11 others
Across 68 payments — averaging $298,123 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$20.2M
- Boehringer Ingelheim Pharma GmbH & Co.kg$113K
- Amgen$6K
What the payments were for
- Consulting fees$1,574,40975%
- Speaking & faculty fees$450,33921%
- Travel & lodging$77,6394%
- Food & beverage$6,0370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Akebia Therapeutics Inc | 101 | $1,317,707 |
| Pharmacosmos Therapeutics Inc. | 108 | $585,121 |
| AstraZeneca | 32 | $54,427 |
| CSL Behring | 27 | $52,811 |
| Astrazeneca AB | 5 | $50,800 |
| Bayer | 21 | $16,808 |
| Ultragenyx Pharmaceutical Inc. | 2 | $9,287 |
| Amgen | 3 | $6,800 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $4,750 |
| AMAG Pharmaceuticals, Inc. | 5 | $4,107 |
| Whitehall International Inc | 1 | $3,250 |
| Diasorin Inc. | 1 | $1,250 |
| Kyowa Kirin Co., Ltd | 3 | $1,111 |
| Travere Therapeutics, Inc. | 1 | $92 |
| OPKO Pharmaceuticals, LLC | 1 | $69 |
| Lupin Inc. | 1 | $21 |
| Novo Nordisk | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,108,424 in reported general payments places this provider in the 95th percentile of 524 nephrology providers in Illinois.
Other nephrology in Chicago
- Susan QuagginChicago$262K
- Nicole StankusChicago$235K
- Marco BonillaChicago$148K
- Lorenzo GallonChicago$120K
- Vikram AggarwalChicago$117K
- Jay KoynerChicago$113K
- Jose ArrudaChicago$107K
- John FriedewaldChicago$93K
- Casey GashtiChicago$74K
- Amr YafiChicago$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.